Profile data is unavailable for this security.
About the company
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
- Revenue in EUR (TTM)3.34bn
- Net income in EUR77.60m
- Incorporated1990
- Employees14.14k
- LocationSartorius AGOtto-Brenner-Str. 20GOETTINGEN 37079GermanyDEU
- Phone+49 5513080
- Fax+49 5 513083289
- Websitehttps://www.sartorius.com/
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 31 Dec 2023 | 911.51k | 2.44% |
| The Vanguard Group, Inc.as of 04 Sep 2024 | 255.81k | 0.68% |
| Carmignac Gestion Luxembourg SA (UK)as of 30 Aug 2024 | 84.99k | 0.23% |
| ProfitlichSchmidlin AGas of 28 Jun 2024 | 74.59k | 0.20% |
| APG Asset Management NVas of 31 Dec 2023 | 49.06k | 0.13% |
| Keskin�inen El�kevakuutusyhti� Ilmarinenas of 31 Dec 2022 | 19.63k | 0.05% |
| Union Investment Privatfonds GmbHas of 31 Mar 2024 | 14.20k | 0.04% |
| Guardians of New Zealand Superannuationas of 30 Jun 2023 | 9.86k | 0.03% |
| KBC Asset Management NVas of 31 Dec 2023 | 7.06k | 0.02% |
| Vanguard Global Advisers LLCas of 31 Aug 2024 | 6.20k | 0.02% |
